CRISM Therapeutics Corporation Net Asset Quality Index
CRISM Therapeutics Corporation net asset quality index. CRISM Therapeutics Corporation (CRTX) has a Net Asset Quality Index of 88.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX2.92 Million minus total liabilities of GBX343.00K yields net assets of GBX2.58 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of CRISM Therapeutics Corporation to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of CRISM Therapeutics Corporation (2006–2025)
Net asset quality index of CRISM Therapeutics Corporation from 2006 to 2025. This chart shows how CRISM Therapeutics Corporation's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of June 2026, the index stands at 88.3%, representing net assets of GBX2.58 Million against total assets of GBX2.92 Million GBX. See CRISM Therapeutics Corporation net assets for net asset value and shareholders' equity analysis.
CRISM Therapeutics Corporation Net Asset Quality Index by Year (2006–2025)
CRISM Therapeutics Corporation net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for CRISM Therapeutics Corporation from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CRISM Therapeutics Corporation (CRTX) market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 78.8% | GBX1.42 Million | GBX1.80 Million | GBX381.00K | ▼ -2.4 pp |
| 2024 | 81.2% | GBX1.48 Million | GBX1.82 Million | GBX341.00K | ▲ +554.5 pp |
| 2023 | -473.2% | GBX-759.66K | GBX160.53K | GBX920.19K | ▼ -570.0 pp |
| 2022 | 96.8% | GBX23.13 Million | GBX23.89 Million | GBX765.65K | ▲ +0.4 pp |
| 2021 | 96.4% | GBX30.11 Million | GBX31.24 Million | GBX1.13 Million | ▼ -0.4 pp |
| 2020 | 96.7% | GBX31.35 Million | GBX32.40 Million | GBX1.05 Million | ▲ +0.7 pp |
| 2019 | 96.0% | GBX20.48 Million | GBX21.34 Million | GBX852.24K | ▲ +6.5 pp |
| 2018 | 89.5% | GBX23.48 Million | GBX26.24 Million | GBX2.76 Million | ▼ -7.3 pp |
| 2017 | 96.8% | GBX28.20 Million | GBX29.14 Million | GBX944.00K | ▲ +9.9 pp |
| 2016 | 86.8% | GBX25.55 Million | GBX29.43 Million | GBX3.88 Million | ▼ -8.7 pp |
| 2015 | 95.5% | GBX15.21 Million | GBX15.91 Million | GBX709.20K | ▼ -2.5 pp |
| 2014 | 98.1% | GBX20.72 Million | GBX21.12 Million | GBX407.00K | ▼ -1.5 pp |
| 2013 | 99.6% | GBX18.05 Million | GBX18.13 Million | GBX74.25K | ▲ +0.0 pp |
| 2012 | 99.5% | GBX16.12 Million | GBX16.19 Million | GBX73.21K | ▲ +0.0 pp |
| 2011 | 99.5% | GBX21.19 Million | GBX21.29 Million | GBX102.00K | ▲ +0.0 pp |
| 2010 | 99.5% | GBX21.29 Million | GBX21.40 Million | GBX109.60K | ▲ +1.2 pp |
| 2009 | 98.3% | GBX16.52 Million | GBX16.81 Million | GBX289.43K | ▲ +0.9 pp |
| 2008 | 97.4% | GBX10.78 Million | GBX11.07 Million | GBX292.12K | ▼ 0.0 pp |
| 2007 | 97.4% | GBX6.53 Million | GBX6.71 Million | GBX175.32K | ▼ -2.4 pp |
| 2006 | 99.8% | GBX9.33 Million | GBX9.35 Million | GBX15.71K | — |